【摘 要】
：
目的 探讨使用Silensor IL 型矫治器干预治疗颈动脉粥样硬化伴OSAHS患者对其脑血流储备力的影响.方法 纳入46 例经颈动脉超声检查和PSG 监测确诊为颈动脉粥样硬化伴OSAHS 患者,在Silensor IL 型矫治器治疗前和治疗1个月后,进行屏气试验比较其BHI 指数的变化,同时行PSG 监测复查疗效.结果 46 例患者中41 例OSAHS 治疗有效,有效率达89＃.患者戴用Sile
【机 构】
：
首都医科大学宣武医院,北京100053
论文部分内容阅读
目的 探讨使用Silensor IL 型矫治器干预治疗颈动脉粥样硬化伴OSAHS患者对其脑血流储备力的影响.方法 纳入46 例经颈动脉超声检查和PSG 监测确诊为颈动脉粥样硬化伴OSAHS 患者,在Silensor IL 型矫治器治疗前和治疗1个月后,进行屏气试验比较其BHI 指数的变化,同时行PSG 监测复查疗效.结果 46 例患者中41 例OSAHS 治疗有效,有效率达89＃.患者戴用Silensor IL型矫治器后,AHI 指数降低,最长呼吸暂停时间减少和氧减百分时间降低,均有统计学显著差异(P＜0.01)；最低血氧饱和度升高,有统计学差异(P＜0.05),深睡眠期及快动眼期睡眠时间百分比也明显增加(P＜0.05).同时BHI 指数显著增加(P＜0.01),提示患者脑血流储备力明显提升,且戴用矫治器前后BHI 指数变化与氧减百分时间的变化呈正相关(P＜0.05).而5 例治疗无效患者BMI 指数明显高于41 例有效患者,治疗前后BHI 指数变化未见统计学差异.结论 使用Silensor IL 型矫治器有效治疗OSAHS,能在短期内显著提高颈动脉粥样硬化伴OSAHS 患者的脑血流储备力.
其他文献
BACKGROUND:The purpose of this observational study was to investigate the relationship between upper-airway configuration assessed by CT imaging during the Müller maneuver state and the severity of ob
Introduction Obstructive sleep apnea(OSA)has been suggested to be a potential contributing factor for nonalcoholic fatty liver disease(NAFLD).Studies on the association between continuous positive air
The coexistence of chronic obstructive pulmonary disease(COPD)and obstructive sleep apnea syndrome(OSA)is known as overlap syndrome.Globally,the incidence of overlap syndrome in individuals >40 years
目的：探讨BiPAP 呼吸机治疗重度阻塞性睡眠呼吸暂停综合征的临床意义。方法：回顾性分析2013年1月～2017年1月收治其中的30例重度阻塞性睡眠呼吸暂停综合征患者，对比观察患者治疗前后临床指标。结果：治疗前后4＃的氧减指数(ODI4)、基础氧饱和度、最低氧饱和度明显提高。结论：BiPAP呼吸机是治疗重度阻塞性睡眠呼吸暂停综合征的有效方法之一。
Purpose Abnormal structure or function in the central nervous system(CNS)can also affect obstructive sleep apnea(OSA).Because human afferent and motor pathways that reg-ulate apnea are still poorly un
Subjective daytime sleepiness is considered a significant risk factor of hypertension in patients with obstructive sleep apnea(OSA).In this study,our goal was to examine the joint effect on hypertensi
Objective The aim of this study was to compare serum leptin,apolipoprotein A1(ApoA1),apolipoprotein J(ApoJ),and apolipoprotein H(ApoH)levels in males with obstructive sleep apnea and hypopnea syndrome